Skip to main content

Advertisement

SpringerLink
Log in

Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis

  • Review Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The onset of early and/or late seizures in brain injured patients is associated with worse outcome. So far, phenytoin is the most commonly used antiepileptic drug to prevent seizures in this group of patients. Objective In the current metaanalysis, we aimed to compare the efficacy and safety of phenytoin versus levetiracetam for seizure prophylaxis in brain injured patients. Methods A systematic search was conducted in PubMed and Cochrane Library Database by 2 investigators. Four randomized controlled trials (RCTs) were included (295 patients). Data were extracted and the quality of each RCT was assessed. Results Levetiracetam was found to be more effective than phenytoin in seizure prophylaxis (OR = 0.23; CI 95% [0.09–0.56]; Q test p value = 0.18 and I2 = 38%). A trend toward less serious side effects was also found in patients treated with levetiracetam (OR = 0.27; CI 95% [0.07–1.07]; Q test p value = 0.72 and I2 = 0%). Conclusion Levetiracetam is more effective and safer than phenytoin for seizure prophylaxis in brain injured patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Claassen J, Vespa P. Electrophysiologic monitoring in acute brain injury. Neurocrit Care. 2014;21(Suppl 2):S129–47.

    Article  PubMed  Google Scholar 

  2. Rowe AS, Goodwin H, Brophy GM, Bushwitz J, Castle A, Deen D, et al. Seizure prophylaxis in neurocritical care: a review of evidence-based support. Pharmacotherapy. 2014;34(4):396–409.

    Article  PubMed  Google Scholar 

  3. Pascarella A, Trojano L, Loreto V, Bilo L, Moretta P, Estraneo A. Long-term outcome of patients with disorders of consciousness with and without epileptiform activity and seizures: a prospective single centre cohort study. J Neurol. 2016;263(10):2048–56.

    Article  PubMed  Google Scholar 

  4. Huang CW, Saposnik G, Fang J, Steven DA, Burneo JG. Influence of seizures on stroke outcomes: a large multicenter study. Neurology. 2014;82(9):768–76.

    Article  PubMed  Google Scholar 

  5. Asikainen I, Kaste M, Sarna S. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia. 1999;40(5):584–9.

    Article  CAS  PubMed  Google Scholar 

  6. Verellen RM, Cavazos JE. Post-traumatic epilepsy: an overview. Therapy. 2010;7(5):527–31.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. J neurotrauma. 2007;24(Suppl 1):S83–6.

    PubMed  Google Scholar 

  8. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655–711.

    Article  PubMed  Google Scholar 

  9. Temkin NR, Haglund MM, Winn HR. Causes, prevention, and treatment of post-traumatic epilepsy. New Horiz. 1995;3(3):518–22.

    CAS  PubMed  Google Scholar 

  10. Burneo JG, Anandan JV, Barkley GL. A prospective study of the incidence of the purple glove syndrome. Epilepsia. 2001;42(9):1156–9.

    Article  CAS  PubMed  Google Scholar 

  11. Appleton RE, Gill A. Adverse events associated with intravenous phenytoin in children: a prospective study. Seizure. 2003;12(6):369–72.

    Article  PubMed  Google Scholar 

  12. Zafar SN, Khan AA, Ghauri AA, Shamim MS. Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury—a meta analysis. BMC Neurol. 2012;12:30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Onkologie. 2000;23(6):597–602.

    PubMed  Google Scholar 

  16. Iuchi T, Kuwabara K, Matsumoto M, Kawasaki K, Hasegawa Y, Sakaida T. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study. J Neurol Neurosurg Psychiatry. 2015;86(10):1158–62.

    Article  PubMed  Google Scholar 

  17. Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, et al. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol. 2009;93(3):349–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Fuller KL, Wang YY, Cook MJ, Murphy MA, D’Souza WJ. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia. 2013;54(1):45–57.

    Article  CAS  PubMed  Google Scholar 

  19. Szaflarski JP, Sangha KS, Lindsell CJ, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care. 2010;12(2):165–72.

    Article  CAS  PubMed  Google Scholar 

  20. Bowman SM, Aitken ME, Sharp GB. Disparities in hospital outcomes for injured people with epilepsy/seizures. Epilepsia. 2010;51(5):862–7.

    Article  PubMed  Google Scholar 

  21. Feleppa M, Di Iorio W, Saracino DM. Early poststroke seizures. Clin Exp Hypertens. 2006;28(3–4):265–70.

    Article  PubMed  Google Scholar 

  22. Bryndziar T, Sedova P, Kramer NM, Mandrekar J, Mikulik R, Brown RD Jr, et al. Seizures following ischemic stroke: frequency of occurrence and impact on outcome in a long-term population-based study. J Stroke Cerebrovasc Dis. 2016;25(1):150–6.

    Article  PubMed  Google Scholar 

  23. Swisher CB, Shah D, Sinha SR, Husain AM. Baseline EEG pattern on continuous ICU EEG monitoring and incidence of seizures. J Clin Neurophysiol. 2015;32(2):147–51.

    Article  PubMed  Google Scholar 

  24. Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743–8.

    Article  CAS  PubMed  Google Scholar 

  25. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323(8):497–502.

    Article  CAS  PubMed  Google Scholar 

  26. Weston J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev. 2015;3:Cd007286.

    Google Scholar 

  27. Naidech AM, Garg RK, Liebling S, Levasseur K, Macken MP, Schuele SU, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40(12):3810–5.

    Article  CAS  PubMed  Google Scholar 

  28. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36(3):583–7.

    Article  CAS  PubMed  Google Scholar 

  29. Choudhari KA, Kaliaperumal C. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery. 2007;61(6):E1340 (author reply E1340).

    Article  PubMed  Google Scholar 

  30. Chumnanvej S, Dunn IF, Kim DH. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery. 2007;60(1):99–102 (discussion 102–103).

    Article  PubMed  Google Scholar 

  31. Jones GL, Wimbish GH, McIntosh WE. Phenytoin: basic and clinical pharmacology. Med Res Rev. 1983;3(4):383–434.

    Article  CAS  PubMed  Google Scholar 

  32. Tobler A, Hosli R, Muhlebach S, Huber A. Free phenytoin assessment in patients: measured versus calculated blood serum levels. Int J Clin Pharm. 2016;38(2):303–9.

    Article  CAS  PubMed  Google Scholar 

  33. Dager WE, Inciardi JF, Howe TL. Estimating phenytoin concentrations by the Sheiner-Tozer method in adults with pronounced hypoalbuminemia. Ann Pharmacother. 1995;29(7–8):667–70.

    Article  CAS  PubMed  Google Scholar 

  34. Dewolfe JL, Szaflarski JP. Levetiracetam use in the critical care setting. Front Neurol. 2013;4:121.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 2000;85(2):77–85.

    Article  CAS  PubMed  Google Scholar 

  36. Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia. 2001;42(4):24–7.

    Article  PubMed  Google Scholar 

  37. Briggs DE, French JA. Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opin Drug Saf. 2004;3(5):415–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King Hamad University Hospital, Muharraq, Bahrain

    Anis Chaari, Alaa Sayed Mohamed, Karim Abdelhakim, Vipin Kauts & William Francis Casey

Authors
  1. Anis Chaari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alaa Sayed Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karim Abdelhakim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vipin Kauts
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William Francis Casey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anis Chaari.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chaari, A., Mohamed, A.S., Abdelhakim, K. et al. Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis. Int J Clin Pharm 39, 998–1003 (2017). https://doi.org/10.1007/s11096-017-0507-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-017-0507-6

Keywords

Search

Navigation